|
Delayed
NYSE
11:36:10 01/10/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 1.130 USD | +0.89% |
|
-5.04% | -16.91% |
| 15/08 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 15/08 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.89% | -5.04% | +13.51% | +15.33% | -16.91% | -29.38% | -79.82% | -86.83% | -97.27% | 35.21M | |
| +4.16% | -0.36% | +8.11% | +34.40% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.46B | |
| +0.80% | +2.25% | -3.68% | +7.56% | +19.08% | +29.06% | +82.78% | +225.18% | +5,541.77% | 60.14B | |
| -1.53% | -0.21% | -1.56% | +1.10% | +5.76% | +6.40% | +35.27% | -18.18% | +204.99% | 48.15B | |
| -0.38% | -2.77% | +3.50% | +31.59% | +18.63% | +31.21% | +37.92% | +10.70% | +233.42% | 44.25B | |
| +1.23% | +3.96% | -1.00% | +10.80% | +160.85% | +353.05% | +693.92% | +613.50% | - | 43.99B | |
| +0.73% | +2.69% | +3.06% | +27.14% | +21.67% | +10.29% | +107.08% | +3.62% | +1,092.39% | 41.61B | |
| -0.67% | +0.17% | -5.93% | +2.54% | +3.09% | +7.60% | +46.37% | -16.71% | +137.67% | 29.97B | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +22.78% | -55.69% | - | 29.31B | |
| -0.27% | -4.42% | -4.39% | +8.57% | -33.25% | -21.12% | +357.92% | +324.31% | +697.91% | 24.93B | |
| +0.79% | -0.82% | -3.43% | +4.82% | +3.41% | -3.68% | -12.68% | -61.36% | - | 24.69B | |
| +0.09% | +3.97% | +9.83% | +31.00% | +16.33% | +18.70% | -3.52% | -14.44% | +106.48% | 21.27B | |
| +0.05% | +1.06% | +7.54% | +15.38% | +11.67% | +15.31% | +158.57% | +220.60% | +1,954.32% | 17.42B | |
| +1.67% | +3.40% | -12.90% | +0.58% | +186.76% | +161.70% | +345.14% | +1,588.11% | +667.01% | 15.8B | |
| -0.11% | -3.58% | +4.72% | +9.47% | +20.10% | +18.84% | +43.18% | -29.22% | +82.07% | 14.79B | |
| +0.22% | -1.31% | -12.51% | -14.98% | - | - | - | - | - | 14.96B | |
| -1.01% | -1.24% | +30.43% | +31.85% | +37.54% | -7.70% | - | - | - | 14.78B | |
| +0.39% | +2.11% | +4.01% | +9.66% | +35.00% | +43.62% | +166.29% | +174.70% | +365.17% | 14.47B | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +535.77% | - | - | 14.83B | |
| +0.40% | -0.25% | +4.03% | +28.21% | +47.24% | +72.28% | +51.87% | -29.51% | +250.99% | 14.08B | |
| Average | +0.83% | +1.84% | +2.80% | +16.43% | +38.11% | +41.43% | +149.06% | +168.13% | +864.38% | 28.2B | |
| Weighted average by Cap. | +1.06% | +1.78% | +2.06% | +18.32% | +43.82% | +52.31% | +151.40% | +145.81% | +1,375.91% |
- Stock Market
- Stocks
- ATNM Stock
- Sector Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
